Lv1
62 积分 2024-01-15 加入
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
7天前
已完结
Drug firms’ secret data supercharge AI protein models
7天前
已完结
Leveraging Structure-Based Design to Overcome Class III RTK Off-Target Activity in the Development of Selective Wild-Type KIT Inhibitors
17天前
已完结
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
19天前
已完结
Azacitidine–Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia
19天前
已完结
Two methods for spirothiohydantoin synthesis
28天前
已关闭
The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
29天前
已完结
Physiological Parameters in Laboratory Animals and Humans
29天前
已完结
Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements
29天前
已完结
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
1个月前
已完结
皖公网安备34019202002308
